These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10703667)

  • 21. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
    Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.
    Neves PDMM; Souza RA; Torres FM; Reis FA; Pinheiro RB; Dias CB; Yu L; Woronik V; Furukawa LS; Cavalcante LB; de Almeida Araújo S; Wanderley DC; Malheiros DM; Jorge LB
    PLoS One; 2020; 15(11):e0233199. PubMed ID: 33147224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podocyte Involvement in Renal Thrombotic Microangiopathy: A Clinicopathological Study.
    Hu YF; Tan Y; Yu XJ; Wang H; Wang SX; Yu F; Zhao MH
    Am J Nephrol; 2020; 51(9):752-760. PubMed ID: 32862175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis.
    Pattanashetti N; Anakutti H; Ramachandran R; Rathi M; Sharma A; Nada R; Gupta KL
    Kidney Int Rep; 2017 Sep; 2(5):844-849. PubMed ID: 29270491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma.
    Herrmann K; Schulze E; Heckmann M; Schubert I; Meurer M; Ziegler V; Haustein UF; Mehlhorn J; Krieg T
    Br J Dermatol; 1990 Jul; 123(1):1-7. PubMed ID: 2117968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Chen SF; Wang H; Huang YM; Li ZY; Wang SX; Yu F; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2015 May; 10(5):750-8. PubMed ID: 25749534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis.
    Saha BK; Saha A; Chong W; Beegle S
    Am J Med Sci; 2020 May; 359(5):296-302. PubMed ID: 32265009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy.
    Moll S; Nickeleit V; Mueller-Brand J; Brunner FP; Maecke HR; Mihatsch MJ
    Am J Kidney Dis; 2001 Apr; 37(4):847-51. PubMed ID: 11273886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy.
    Okazaki R; Matsuoka K; Horiuchi A; Maruyama K; Okazaki I
    Diabetes Res Clin Pract; 1988 Sep; 5(3):163-70. PubMed ID: 3219988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics and Prognosis of Renal Thrombotic Microangiopathy in Lupus Nephritis.
    Chen X; Cheng W; Wang G; Qi Y; Xiao J; Wang X; Zhao Z
    Iran J Kidney Dis; 2021 May; 15(3):169-176. PubMed ID: 33994376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels and molecular size distribution of serum laminin in adult type I diabetic patients with and without microangiopathy.
    Werle E; Diehl E; Hasslacher C
    Metabolism; 1998 Jan; 47(1):63-9. PubMed ID: 9440479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum laminin P1 in chronic viral hepatitis: correlations with liver histological activity and diagnostic value.
    Gabrielli GB; Capra F; Casaril M; Corrocher R; Colombari R; De Sandre G
    Clin Chim Acta; 1996 Aug; 252(2):171-80. PubMed ID: 8853564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of renal vascular pathology in lupus nephritis.
    Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R; Morales-Buenrostro LE
    Lupus; 2017 Sep; 26(10):1042-1050. PubMed ID: 28178879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal thrombotic microangiopathies induced by severe hypertension.
    Zhang B; Xing C; Yu X; Sun B; Zhao X; Qian J
    Hypertens Res; 2008 Mar; 31(3):479-83. PubMed ID: 18497467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study.
    Li QY; Yu F; Zhou FD; Zhao MH
    Medicine (Baltimore); 2016 May; 95(18):e3595. PubMed ID: 27149490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process?
    Rollino C; Mazzucco G; Boero R; Beltrame G; Quattrocchio G; Ferro M; Milan M; Berruti S; Quarello F
    Ren Fail; 2003 Nov; 25(6):1043-9. PubMed ID: 14669864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laminin P1 and procollagen III peptide in serum: activity parameters in chronic inflammatory joint diseases].
    Schneider M; Lohmann J; Gerlach U
    Z Rheumatol; 1988; 47(2):93-7. PubMed ID: 3388992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to alpha interferon therapy in HCV chronic liver disease: role of hepatic fibrosis.
    Di Costanzo GG; Ascione A; Lanza AG; De Luca M; Bracco A; Lojodice D; Marsilia GM; Ferbo U
    Ital J Gastroenterol; 1996 Apr; 28(3):140-6. PubMed ID: 8789824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.